KOSPI · Healthcare · ₩180B
₩7,710+0.92%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 6.7% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“이번 분기, 해외 생산 기반을 키우며 다음 성장을 준비해요.”
In the company's words · 2026 2분기 filing